Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
This article examines Why Do Stablecoins Fail, focusing on reserve adequacy, liquidity mismanagement, and governance gaps that threaten peg stability.
18,122 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
With $1,000, you can build a resilient, diversified starter portfolio. This guide shows how to pick the best stocks w...
A big-name hedge fund recently disclosed a fresh stake in a leading utility company, adding roughly 1.9 million share...
Could 2026 bring a surprise policy pivot? This guide explains why the Fed might hike instead of cutting, how that sce...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
A sharp dip can set off alarm bells, but it can also open doors. This article digs into why Qualcomm stock down 28% h...
Icahn Enterprises just added a sizable stake in Centuri Holdings, signaling a continued conviction in North America's...
Curious about whether Blue Owl Capital can outperform the market? This guide breaks down what to watch, how to analyz...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
When insiders sell, investors watch closely. This article unpacks a recent move at Laureate Education and translates ...
A 20-year-old caller on The Ramsey Show is urged to cancel a $28,000 car loan after a rising debt load, underscoring ...